QUT Centre for Vision and Eye Research Showcase: Paediatrics and Myopia
Date: 23/11/2025 (AEST)
Venue: https://research.qut.edu.au/ver/cver-showcase-paediatrics-and-myopia/, QLD, 4059
Provider: Queensland University of Technology, Centre for Vision and Eye Research
Contact: Stephen Vincent, [E] sj.vincent@qut.edu.au, [P] 0412374958
Activity Outline
This face-to-face event will take place over one day (5 hours education total), consisting of seven sessions including an interactive panel discussion at the end of each session. Lectures will be delivered by optometrists and vision scientists from QUT's Centre for Vision and Eye Research with a focus on the latest evidence in paediatrics and myopia control including amblyopia, Indigenous paediatric optometry research, clinical considerations in paediatric populations, visual and biometric measurements in children, and myopia (atropine, optics, and the environment).
Learning Objectives
- Discuss the importance of assessing quality of life in patients with amblyopia and that binocular functional performance in not explained by monocular acuity deficits
- Describe new modes of cycloplegic drug delivery
- Discuss the principles of cultural safety in research and the process of developing a visual acuity optotype for Aboriginal and Torres Strait Islander children
- Discuss the effect of low dose atropine on ocular biometry, accommodation and vergence systems, and the choroid
- Describe the effect of blue light and ambient light exposure upon ocular parameters
- Discuss the association between eye movements and academic performance in children, the visual manifestations of cerebral visual impairment, and various presentations of paediatric ocular pathology
- Describe new psychophysical procedures to quantify visual acuity in preschoolers
- Discuss the ocular response to different myopia control treatments
Max CPD hours awarded: 5
Session Information
| Name |
|---|
| The effect of low dose atropine on ocular biometry |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Response of accommodation and vergence systems to low dose atropine |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Choroidal changes during and after discontinuing long-term 0.01% atropine treatment for myopia control |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Blue light stimulation of the optic nerve head |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Light exposure and the choroid |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Real-time near vision behaviour and light exposure in myopic children using different myopia control treatments |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Genetics, environment, and ocular biometry in myopia |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Eye movements and academic performance in children |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Visual manifestations of cerebral visual impairment |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Paediatric ocular oncology |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Impact of simulated blur on visual performance measured with turtle optotype (developed for use with First Nations communities) |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Optical measurements in children |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Improving psychophysical procedures in preschool visual acuity measurements |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Novel optical ideas for myopia |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| The ocular response to multifocal soft contact lenses |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Myopia control spectacle lenses |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Deficits in binocular functional performance in adults with amblyopia are not explained by monocular acuity reduction |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Assessing quality of life in amblyopia |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Improving the patient experience: cycloplegic drug delivery |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| Yes |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name |
|---|
| Development of a re-designed 'Turtle' optotype for testing visual acuity in Aboriginal and Torres Strait Islander children |
| Clinical? |
|---|
| Yes |
| Interactive? |
|---|
| Yes |
| Therapeutic? |
|---|
| No |
| Duration of CPD Session/Module |
|---|
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
|---|
| 0.25 |
| Name | Clinical? | Interactive? | Therapeutic? | CPD Hours |
|---|
| The effect of low dose atropine on ocular biometry | Yes | Yes | Yes | 0.25 | 0.25 |
| Response of accommodation and vergence systems to low dose atropine | Yes | Yes | Yes | 0.25 | 0.25 |
| Choroidal changes during and after discontinuing long-term 0.01% atropine treatment for myopia control | Yes | Yes | Yes | 0.25 | 0.25 |
| Blue light stimulation of the optic nerve head | Yes | Yes | No | 0.25 | 0.25 |
| Light exposure and the choroid | Yes | Yes | No | 0.25 | 0.25 |
| Real-time near vision behaviour and light exposure in myopic children using different myopia control treatments | Yes | Yes | No | 0.25 | 0.25 |
| Genetics, environment, and ocular biometry in myopia | Yes | Yes | No | 0.25 | 0.25 |
| Eye movements and academic performance in children | Yes | Yes | No | 0.25 | 0.25 |
| Visual manifestations of cerebral visual impairment | Yes | Yes | No | 0.25 | 0.25 |
| Paediatric ocular oncology | Yes | Yes | No | 0.25 | 0.25 |
| Impact of simulated blur on visual performance measured with turtle optotype (developed for use with First Nations communities) | Yes | Yes | No | 0.25 | 0.25 |
| Optical measurements in children | Yes | Yes | No | 0.25 | 0.25 |
| Improving psychophysical procedures in preschool visual acuity measurements | Yes | Yes | No | 0.25 | 0.25 |
| Novel optical ideas for myopia | Yes | Yes | No | 0.25 | 0.25 |
| The ocular response to multifocal soft contact lenses | Yes | Yes | No | 0.25 | 0.25 |
| Myopia control spectacle lenses | Yes | Yes | No | 0.25 | 0.25 |
| Deficits in binocular functional performance in adults with amblyopia are not explained by monocular acuity reduction | Yes | Yes | No | 0.25 | 0.25 |
| Assessing quality of life in amblyopia | Yes | Yes | No | 0.25 | 0.25 |
| Improving the patient experience: cycloplegic drug delivery | Yes | Yes | Yes | 0.25 | 0.25 |
| Development of a re-designed 'Turtle' optotype for testing visual acuity in Aboriginal and Torres Strait Islander children | Yes | Yes | No | 0.25 | 0.25 |